Background: Intermediate-to-high-risk prostate cancer can locally invade seminal vesicle (SV). It is recommended that anatomic proximal 1-cm to 2-cm SV be included in the clinical target volume (CTV) for definitive radiotherapy based on pathology studies. However, it remains unclear whether the pathology indicated SV extent is included into the CTV defined by current guidelines. The purpose of this study is to compare the volume of proximal SV included in CTV defined by EORTC prostate cancer radiotherapy guideline and RTOG0815 protocol with the actual anatomic volume. Methods: Radiotherapy planning CT images from 114 patients with intermediate-(36.8%) or high-risk (63.2%) prostate cancer were reconstructed with 1-mm-thick sections. The s...
OBJECTIVES:No study has reported clinical results of external-beam radiotherapy specifically for T3b...
National audienceThe knowledge of inter- and intrafraction motion and deformations of the intrapelvi...
Objectives: The pre-treatment risk of seminal vesicle (SV) invasion (SVI) from prostate cancer is cu...
INTRODUCTION: Guidelines recommend that the proximal seminal vesicles (PrSV) should be included in t...
International audiencePURPOSE: To quantify the prostate and seminal vesicles (SV) anatomic variation...
BACKGROUND: To analyze interfraction motion of seminal vesicles (SV), and its motion relative to rec...
We investigated differences in seminal vesicle (SV) length and interfractional SV motion relative to...
© Cambridge University Press 2019. Introduction:Prostate positional variability has been widely expl...
Background Pre-treatment magnetic resonance imaging (MRI) can give patient-specific evaluation of 25...
Abstract gepubliseerd in Elsevier: For patients with intermediate- and high risk prostate cancer, ...
A review of studies on seminal vesicle motion was performed to improve the understanding of these tr...
PURPOSE: At present, uniformity does not exist with regard to the indication criteria of seminal ve...
The objectives of this study were to quantify residual interfraction displacement of seminal vesicle...
Purpose: To determine whether a 3-mm isotropic target margin adequately covers the prostate and semi...
ObjectivesNo study has reported clinical results of external-beam radiotherapy specifically for T3b ...
OBJECTIVES:No study has reported clinical results of external-beam radiotherapy specifically for T3b...
National audienceThe knowledge of inter- and intrafraction motion and deformations of the intrapelvi...
Objectives: The pre-treatment risk of seminal vesicle (SV) invasion (SVI) from prostate cancer is cu...
INTRODUCTION: Guidelines recommend that the proximal seminal vesicles (PrSV) should be included in t...
International audiencePURPOSE: To quantify the prostate and seminal vesicles (SV) anatomic variation...
BACKGROUND: To analyze interfraction motion of seminal vesicles (SV), and its motion relative to rec...
We investigated differences in seminal vesicle (SV) length and interfractional SV motion relative to...
© Cambridge University Press 2019. Introduction:Prostate positional variability has been widely expl...
Background Pre-treatment magnetic resonance imaging (MRI) can give patient-specific evaluation of 25...
Abstract gepubliseerd in Elsevier: For patients with intermediate- and high risk prostate cancer, ...
A review of studies on seminal vesicle motion was performed to improve the understanding of these tr...
PURPOSE: At present, uniformity does not exist with regard to the indication criteria of seminal ve...
The objectives of this study were to quantify residual interfraction displacement of seminal vesicle...
Purpose: To determine whether a 3-mm isotropic target margin adequately covers the prostate and semi...
ObjectivesNo study has reported clinical results of external-beam radiotherapy specifically for T3b ...
OBJECTIVES:No study has reported clinical results of external-beam radiotherapy specifically for T3b...
National audienceThe knowledge of inter- and intrafraction motion and deformations of the intrapelvi...
Objectives: The pre-treatment risk of seminal vesicle (SV) invasion (SVI) from prostate cancer is cu...